Neuroprotective effect of astrocyte-derived IL-33 in neonatal hypoxic-ischemic brain injury

• Published in: Journal of neuroinflammation 2020-08, Vol.17 (1), p.1-251, Article 251
• Main Authors: Jiao, Mengya, Li, Xiangyong, Chen, Liying, Wang, Xiaodi, Yuan, Baohong, Liu, Tao, Dong, Qun, Mei, Hanfang, Yin, Hui
• Format: Article
• Language: English
• Subjects: Apoptosis; Astrocytes; Brain; Brain injury; Carotid artery; Cell proliferation; Cellular signal transduction; Cerebral blood flow; Cerebral infarction; Experiments; Flow cytometry; Gene expression; Genetic aspects; Glucose; Health aspects; Hypoxia; IL-33; Immunofluorescence; Immunoregulation; Inflammation; Injuries; Interleukins; Ischemia; Kinases; Laboratories; Neonatal hypoxic-ischemic brain injury; Neonates; Neurological diseases; Neuronal-glial interactions; Neurons; Neuroprotection; Neurotrophic factors; ST2; Traumatic brain injury
• ISSN: 1742-2094; 1742-2094
• DOI: 10.1186/s12974-020-01932-z

Background Interleukin-33 (IL-33) is a well-recognized pleiotropic cytokine which plays crucial roles in immune regulation and inflammatory responses. Recent studies suggest that IL-33 and its receptor ST2 are involved in the pathogenesis of neurological diseases. Here, we explore the effect of IL-33/ST2 signaling in neonatal hypoxic-ischemic (HI) brain injury and elucidate the underlying mechanisms of action. Methods The brain HI model was established in neonatal C57BL/6 mice by left common carotid artery occlusion with 90 min hypoxia and treated with IL-33 at a dose of 0.2 μg/day i.p. for 3 days. TTC staining and neurobehavioral observation were used to evaluate the HI brain injury. Immunofluorescence and flow cytometry were applied to determine the expression of IL-33 and its receptor ST2 on brain CNS cells and cell proliferation and apoptosis. OGD experiment was used to assay the viability of astrocytes and neurons. RT-qPCR was used to measure the expression of neurotrophic factor-associated genes. Results The expression level of IL-33 was markedly enhanced in astrocytes 24 h after cerebral HI in neonatal mice. Exogenous delivery of IL-33 significantly alleviated brain injury 7 days after HI, whereas ST2 deficiency exacerbated brain infarction and neurological deficits post HI. Flow cytometry analyses demonstrated high levels of ST2 expression on astrocytes, and the expression of ST2 was further elevated after HI. Intriguingly, IL-33 treatment apparently improved astrocyte response and attenuated HI-induced astrocyte apoptosis through ST2 signaling pathways. Further in vitro studies revealed that IL-33-activated astrocytes released a series of neurotrophic factors, which are critical for raising neuronal survival against oxygen glucose deprivation. Conclusions The activation of IL-33/ST2 signaling in the ischemic brain improves astrocyte response, which in turn affords protection to ischemic neurons in a glial-derived neurotrophic factor-dependent manner.